India's research performance in Pharmacology and Biotechnology indicates that India's scholarly output based on publication data is nearly 5 % of the world's total in 2014 and showing strong average growth of over 12 % annually. Shri Y.S. Chowdary, ... Press Information Bureau, 3 weeks ago
3 images for "biotechnology regulatory authority of india b"
The Foreign Direct Investment Policy (" FDI Policy ") is the primary regulation governing foreign investment in India. The Government of India (" Government ") introduced several amendments to the FDI Policy through the annual Consolidated Foreign ...Gibson Dunn, 1 month ago
The first Indian Pharmacovigilance Day conference will be held in Mumbai on July 29, 2016. Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer of Oviya MedSafe, a global pharmacovigilance consulting and drug safety services, will ...CPhI.cn, 4 weeks ago Dr J Vijay Venkatraman to chair first Indian Pharmacovigilance Day conference on July 29 at Mumbai PharmaBiz, 4 weeks ago Indian Pharmacovigilance Day 2016 to be observed in Mumbai on July 29 PharmaBiz, 2 months ago
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® Brentuximab Vedotin for CD30 Expressing Cutaneous T Cell Lymphoma
Few Sec ago Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) in patients with ...India Online.in, 3 weeks ago Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® Brentuximab Vedotin Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood India Online.in, 1 month ago
LUXEMBOURG--( BUSINESS WIRE )--Regulatory News: Eurofins Scientific (Paris:ERF): Revenues of EUR 1,208m in H1 2016 represent a 43.5% increase over the same period in the previous year. Organic growth 9 during the period was over 11%, the ...Business Wire, 3 weeks ago Growth momentum sustained as strong Q1 operating trends continued in Q2 2016 Eurofins Scientific, 3 weeks ago
More from: WorldRegInfo, Nasdaq...and 3 other sources
PARIS--( BUSINESS WIRE )--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical group, today announced financial results for the first half 2016. The Board of Directors, chaired by Marc de Garidel, met on ...Business Wire, 3 weeks ago Ipsen 's First Half 2016 Results Stockwatch, 3 weeks ago
Upcoming SlideShare Loading in … 5 1. Harmonisation of Food Standards in ASEAN A Shared Vision For Regulatory Convergence FIA Executive Summary 2. Contents Introduction to This Guide Foreword by FIA President ASEAN and the Agro-food ...SlideShare.net, 3 weeks ago
A company logo of Fosun International is seen during the annual general meeting of the Chinese conglomerate, founded by billionaire Guo Guangchang, in Hong Kong, China in this May 28, 2015 file photo. — Reuters pic HONG KONG, July 29 — The ...Malay Mail, 3 weeks ago
1. GMO foods and crops pose health risks Scientific organisations Stijn Bruers' article starts with an appeal to authority in claiming GMOs are safe, that doesn't stand up to scrutiny. He cites a number of respected scientific organisations, ...Corporate Europe Observatory, 1 month ago
As seen in the latest issue of Master Investor Magazine Investors often suppose that biotechnology is all about the development of new wonder drugs which zap bacteria and viruses pharmacology. But in fact the best investment prospects probably ...Master Investor, 1 month ago
on your WebpageAdd Widget >Get your members hooked!